Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to become Interim ...
Zimislecel, Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the ...
A major breakthrough in liquid catalysis is transforming how essential products are made, making the chemical manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback